Decreased serum apolipoprotein AII/AI ratio in systemic amyloidosis

Annals of the Rheumatic Diseases

Volumn 57, Issue 4, 1998, Pages 249-251

  Yamada, Toshiyuki ^a,f   Ozawa, Tetsuo ^b   Gejyo, Fumitake ^c   Okuda, Yasuaki ^d   Takasugi, Kiyoshi ^d   Hotta, Osamu ^e   Itoh, Yoshihisa ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

^c UNIVERSITY OF FUKUI   (Japan)

^d Dohgo Spa Hospital   (Japan)

^e Department of Nephrology Sendai Shakaihoken Hospital   (Japan)

^f Dept of Clinical Pathology ^*  (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2;

ADULT; AMYLOIDOSIS; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HEMODIALYSIS; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELIABILITY; RHEUMATOID ARTHRITIS;

EID: 0031926021     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.57.4.249     Document Type: Article

References (12)

1. Benson MD. Amyloidosis. In: Scriver CR, Beaudet AL, Sly WS, Valle DV, eds. The metabolic basis of inherited disease. 7th ed. New York: McGraw-Hill, 1995:4159-91.
2. Laakso M, Mutru O, Isomaki HA, Koota K. Mortality from amyloidodis and renal diseases in patients with rheumatoid arthritis. Ann Rheum Dis 1986;45:663-7.
3. Okuda Y, Takasugi K, Oyama T, Oyama H, Nanba S, Miyamoto T. Intractable diarrhoea associated with secondary amyloidosis in rheumatoid arthritis. Ann Rheum Dis 1997;56:535-41.
4. Kobayashi H, Tada S, Fuchigami T, Okuda Y, Takasugi K, Matsumoto T, et al. Amyloidosis in rheumatoid arthritis: diagnostic and prognostic value of gastroduodenal biopsy. Br J Rheumatol 1996;35:44-9.
5. Hawkins PN, Myers MJ, Lavender JP, Pepys MB. Diagnostic radionuclide imaging of amyloid: biological targeting by circulating human serum amyloid P component. Lancet 1988;i:1413-18.
6. Ando Y, Tanaka Y, Ueyama H, Sakashita N, Yonehara T, Higuchi K, et al. Low plasma apolipoprotein AII levels in human and mouse amyloidosis with mutant transthretin (Met-30) gene. Ann Neurol 1993;33:101-3.
7. Homma N, Gejyo F, Kobayashi H, Saito H, Sakai S, Suzuki M, et al. Cystic radiolucencies of carpal bones, distal radius and ulna as a marker for dialysis-associated amyloid osteoarthropathy. Nephron 1992;62:6-12.
8. Yamada T, Nomata Y, Sugita O, Okada M. A rapid method for measuring serum amyloid A protein by latex agglutination nephelometric immunoassay. Ann Clin Biochem 1993;30:72-6.
9. Coetzee GA, Strachan AF, van der Westhuyzen DR, Hoppe HC, Jeenah MS, de Beer FC. Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition. J Biol Chem 1986;261:9644-51.
10. Kunisada T, Higuchi K, Aota S, Takeda T, Yamagishi H. Molecular cloning and nucleotide sequence of cDNA for murine senile amyloid protein: nucleotide substitutions found in apolipoprotein A-II cDNA of senescence accelerated mouse (SAM). Nucleic Acids Res 1986;14:5729-40.
11. Tanaka Y, Ando Y, Kumamoto T, Miyazaki A, Kakamura M, Nakayama M, et al. Changed affinity of apolipoprotein AII to high density lipoprotein (HDL) in patients with familial amyloidotic polyneuropathy (FAP) type I. Biochim Biophys Acta 1994;1225:311-16.
12. Nakamura M, Tanaka Y, Ando Y, Yamashita T, Salvi F, Ferlini A, et al. Decreased affinity of apolipoprotein AII to high-density lipoprotein m patients with transthyretin-related amyloidosis (Met30, Gln89, Pro36, and Thr34). Biochem Biophys Res Commun 1996;219:316-21.